Because of its prevalence and the availability of fusion-positive cell line model, the relevance of TMPRSS2-ERG for prostate cancer cells and the clinical manifestations of the disease has been widely studied and will be discussed in more detail in the following chapters. This evidence concerns the gene TMPRSS2 and prostate carcinoma.